Surgical therapy for complex coronary artery disease

Area of Science:

• Cardiology
• Cardiac Surgery
• Interventional Cardiology

Background:

• Coronary artery disease (CAD) management has advanced, improving patient longevity.
• Despite progress, underlying CAD pathology persists, necessitating further treatment options.
• Severe CAD often becomes unsuitable for standard percutaneous coronary intervention (PCI).

Purpose of the Study:

• To review surgical strategies for patients with severe CAD not amenable to PCI.
• To discuss outcomes of repeated coronary artery bypass grafting (CABG) and coronary endarterectomy.
• To explore emerging therapies like transmyocardial revascularization (TMR) and protein/gene therapy for complex CAD.

Main Methods:

• Literature review of surgical options for severe coronary artery disease.
• Analysis of perioperative assessment, procedural details, and outcomes for repeated CABG and endarterectomy.
• Discussion of TMR and protein/gene therapy in extreme CAD cases.

Main Results:

• Repeated CABG and endarterectomy offer viable solutions for select patients with severe CAD.
• TMR and protein/gene therapy represent potential future avenues for refractory CAD.
• Patient selection and surgical expertise are critical for successful outcomes in complex cases.

Conclusions:

• Advanced surgical techniques and novel therapies are crucial for managing complex coronary artery disease.
• These interventions extend options for patients with severe CAD unsuitable for conventional PCI.
• Ongoing research in TMR and gene therapy holds promise for intractable coronary artery disease.